Hamdi Cihan Emeksiz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hamdi Cihan Emeksiz has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Aşan Önder
Medeniyet University Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Pediatric Endocrinology Clinic, Istanbul, Turkey
5 shared publications - Alper Han Cebi
Department of Medical Genetics, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey
3 shared publications - Merve Nur Hepokur
Pediatric Endocrinology Clinic , Istanbul Medeniyet University Faculty of Medicine, Göztepe Prof. Dr. Süleyman Yalçın City Hospital , Istanbul , Türkiye
3 shared publications - Peyami Cinaz
Gazi University Faculty of Medicine, Department of Pediatric Endocrinology, Ankara, Turkey
3 shared publications - Ulas Emre Akbulut
Department of Pediatric Gastroenterology Hepatology and Nutrition, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey
3 shared publications - Ayca Ata Korkmaz
Department of Radiology, Akcaabat State Hospital, Trabzon, Turkey
2 shared publications
Latest Publications
- 14 September 2026
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 39 (11) , 1143-1147
Anti-Müllerian hormone levels in girls with precocious puberty
Objectives: We aimed to evaluate the relationship between anti-Müllerian hormone (AMH) levels in cases of central precocious puberty (CPP), premature adrenarche (PA), and isolated premature thelarche (IPT) and those of healthy controls (HC). Methods: A total of 153 girls (40 PA, 39 CPP, 39 IPT, and 35 HC) were included in the study. AMH levels were assessed using the ELISA method. Results: The mean age of all participants was 7.19 ± 0.63 (5.0–8.0) years. Height SDS was higher in the puberty and puberty variant groups compared with the healthy group. This difference was found to be statistically significant between the CPP and HC groups. Obesity was present in 20 of all participants (13 %). AMH levels were 0.125 ± 0.154, 0.086 ± 0.072, 0.084 ± 0.074, and 0.069 ± ;0.060 ng/mL in PA, PT, CPP, and HC groups, respectively. Although AMH levels were higher in the PA group, there was no statistically significant difference among the four groups. A weak negative correlation was found between AMH levels and BMI SDS (body mass index standard deviation score). Conclusions: AMH levels do not differ between prepubertal girls and those diagnosed with central precocious puberty or a variant of puberty of the same age.
- 14 September 2026
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 39 (11) , 1143-1147
Anti-Müllerian hormone levels in girls with precocious puberty
Objectives: We aimed to evaluate the relationship between anti-Müllerian hormone (AMH) levels in cases of central precocious puberty (CPP), premature adrenarche (PA), and isolated premature thelarche (IPT) and those of healthy controls (HC). Methods: A total of 153 girls (40 PA, 39 CPP, 39 IPT, and 35 HC) were included in the study. AMH levels were assessed using the ELISA method. Results: The mean age of all participants was 7.19 ± 0.63 (5.0–8.0) years. Height SDS was higher in the puberty and puberty variant groups compared with the healthy group. This difference was found to be statistically significant between the CPP and HC groups. Obesity was present in 20 of all participants (13 %). AMH levels were 0.125 ± 0.154, 0.086 ± 0.072, 0.084 ± 0.074, and 0.069 ± ;0.060 ng/mL in PA, PT, CPP, and HC groups, respectively. Although AMH levels were higher in the PA group, there was no statistically significant difference among the four groups. A weak negative correlation was found between AMH levels and BMI SDS (body mass index standard deviation score). Conclusions: AMH levels do not differ between prepubertal girls and those diagnosed with central precocious puberty or a variant of puberty of the same age.
- Open Access
- 27 March 2026
- Published by Galenos Yayinevi in Medeniyet Medical Journal
- Vol. 41 (1) , 69-75
Impact of SARS-CoV-2 Infection on Diabetic Ketoacidosis in Children with Newly Diagnosed Type-1 Diabetes: A Prospective Multicenter Study
Impact of SARS-CoV-2 Infection on Diabetic Ketoacidosis in Children with Newly Diagnosed Type-1 Diabetes: A Prospective Multicenter Study - Medeniyet Medical Journal
- 27 March 2026
- Published by Galenos Yayinevi in Medeniyet Medical Journal
- Vol. 41 (1) , 69-75
Open AccessImpact of SARS-CoV-2 Infection on Diabetic Ketoacidosis in Children with Newly Diagnosed Type-1 Diabetes: A Prospective Multicenter Study
Impact of SARS-CoV-2 Infection on Diabetic Ketoacidosis in Children with Newly Diagnosed Type-1 Diabetes: A Prospective Multicenter Study - Medeniyet Medical Journal
- Open Access
- 4 February 2026
- Published by Pediatric Practice and Research Journal in Pediatric Practice and Research
- Vol. 14 (1) , 1974143
Early Cardiometabolic Characteristics in Childhood Among Large-for-Gestational-Age Infants
Background/Aims: To evaluate cardiometabolic characteristics in prepubertal children born large for gestational age (LGA) compared with those born appropriate for gestational age (AGA), with a focus on adiposity, insulin levels, and lipid parameters.Methods: This study included 117 prepubertal children aged 6–9 years (59 LGA, 58 AGA). Anthropometric measurements, blood pressure, and fasting laboratory parameters were assessed. LGA was defined as birth weight ≥90th percentile for gestational age, and AGA as the 10th–90th percentile. Insulin levels and lipid profiles were evaluated. Statistical analyses included t-tests, Mann–Whitney U tests, and chi-square tests.Results: Children born LGA had significantly higher weight, height, BMI, and waist and hip circumferences compared with AGA peers (p≤0.010). Obesity prevalence was higher in the LGA group (25.4% vs. 10.3%, p=0.030). Fasting glucose and insulin levels were similar between groups. Total cholesterol and LDL-C were significantly higher in LGA children (p=0.010 and p=0.030, respectively), while HDL-C was also higher (p=0.040) and triglyceride levels were lower (p=0.04).Conclusions: Children born LGA showed greater adiposity and higher LDL cholesterol concentrations than AGA peers. Although insulin resistance and elevated blood pressure were not evident at this age, the cross-sectional design and the restriction to offspring of mothers without recognised metabolic disease mean that these findings represent associations rather than evidence of causation and require confirmation in longitudinal studies.
- 4 February 2026
- Published by Pediatric Practice and Research Journal in Pediatric Practice and Research
- Vol. 14 (1) , 1974143
Open AccessEarly Cardiometabolic Characteristics in Childhood Among Large-for-Gestational-Age Infants
Background/Aims: To evaluate cardiometabolic characteristics in prepubertal children born large for gestational age (LGA) compared with those born appropriate for gestational age (AGA), with a focus on adiposity, insulin levels, and lipid parameters.Methods: This study included 117 prepubertal children aged 6–9 years (59 LGA, 58 AGA). Anthropometric measurements, blood pressure, and fasting laboratory parameters were assessed. LGA was defined as birth weight ≥90th percentile for gestational age, and AGA as the 10th–90th percentile. Insulin levels and lipid profiles were evaluated. Statistical analyses included t-tests, Mann–Whitney U tests, and chi-square tests.Results: Children born LGA had significantly higher weight, height, BMI, and waist and hip circumferences compared with AGA peers (p≤0.010). Obesity prevalence was higher in the LGA group (25.4% vs. 10.3%, p=0.030). Fasting glucose and insulin levels were similar between groups. Total cholesterol and LDL-C were significantly higher in LGA children (p=0.010 and p=0.030, respectively), while HDL-C was also higher (p=0.040) and triglyceride levels were lower (p=0.04).Conclusions: Children born LGA showed greater adiposity and higher LDL cholesterol concentrations than AGA peers. Although insulin resistance and elevated blood pressure were not evident at this age, the cross-sectional design and the restriction to offspring of mothers without recognised metabolic disease mean that these findings represent associations rather than evidence of causation and require confirmation in longitudinal studies.
- 1 January 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (01) , 65-69
Evaluation of plasma microRNA expressions in children with metabolic dysfunction-associated steatotic liver disease
- 1 January 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (01) , 65-69
Evaluation of plasma microRNA expressions in children with metabolic dysfunction-associated steatotic liver disease
- Open Access
- 7 July 2025
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 18 (1) , 66-73
Comparison of Methods Used for Final Height Prediction in Central Precocious Puberty Patients
Comparison of Methods Used for Final Height Prediction in Central Precocious Puberty Patients - Journal of Clinical Research in Pediatric Endocrinology
- 7 July 2025
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 18 (1) , 66-73
Open AccessComparison of Methods Used for Final Height Prediction in Central Precocious Puberty Patients
Comparison of Methods Used for Final Height Prediction in Central Precocious Puberty Patients - Journal of Clinical Research in Pediatric Endocrinology
- Open Access
- 23 December 2024
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 17 (2) , 185-190
Adaptation/Validity-reliability Evaluation of Menstruel Bleeding Questionnaire to Turkish Adolescent Girls
Journal of Clinical Research in Pediatric Endocrinology
- 23 December 2024
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 17 (2) , 185-190
Open AccessAdaptation/Validity-reliability Evaluation of Menstruel Bleeding Questionnaire to Turkish Adolescent Girls
Journal of Clinical Research in Pediatric Endocrinology
- 13 January 2022
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 107 (5) , e1924-e1931
Steroid Hormone Profiles and Molecular Diagnostic Tools in Pediatric Patients With non-CAH Primary Adrenal Insufficiency
Context There is a significant challenge of attributing specific diagnoses to patients with primary adrenal insufficiency of unknown etiology other than congenital adrenal hyperplasia (non-CAH PAI). Specific diagnoses per se may guide personalized treatment or may illuminate pathophysiology. Objective This work aimed to investigate the efficacy of steroid hormone profiles and high-throughput sequencing methods in establishing the etiology in non-CAH PAI of unknown origin. Methods Pediatric patients with non-CAH PAI whose etiology could not be established by clinical and biochemical characteristics were enrolled. Genetic analysis was performed using targeted-gene panel sequencing (TPS) and whole-exome sequencing (WES). Plasma adrenal steroids were quantified by liquid chromatography–mass spectrometry and compared to that of controls. This study comprised 18 pediatric endocrinology clinics with 41 patients (17 girls, median age: 3 mo, range: 0-8 y) with non-CAH PAI of unknown etiology. Results A genetic diagnosis was obtained in 29 (70.7%) patients by TPS. Further molecular diagnosis could not be achieved by WES. Compared to a healthy control group, patients showed lower steroid concentrations, most statistically significantly in cortisone, cortisol, and corticosterone (P < .0001, area under the receiver operating characteristic curve: .96, .88, and .87, respectively). Plasma cortisol of less than 4 ng/mL, cortisone of less than 11 ng/mL, and corticosterone of less than 0.11 ng/mL had a greater than 95% specificity to ensure the diagnosis of non-CAH PAI of unknown etiology. Conclusion Steroid hormone profiles are highly sensitive for the diagnosis of non-CAH PAI of unknown etiology, but they are unlikely to point to a specific molecular diagnosis. TPS is an optimal approach in the molecular diagnosis of these patients with high efficacy, whereas little additional benefit is expected from WES.
- 13 January 2022
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 107 (5) , e1924-e1931
Steroid Hormone Profiles and Molecular Diagnostic Tools in Pediatric Patients With non-CAH Primary Adrenal Insufficiency
Context There is a significant challenge of attributing specific diagnoses to patients with primary adrenal insufficiency of unknown etiology other than congenital adrenal hyperplasia (non-CAH PAI). Specific diagnoses per se may guide personalized treatment or may illuminate pathophysiology. Objective This work aimed to investigate the efficacy of steroid hormone profiles and high-throughput sequencing methods in establishing the etiology in non-CAH PAI of unknown origin. Methods Pediatric patients with non-CAH PAI whose etiology could not be established by clinical and biochemical characteristics were enrolled. Genetic analysis was performed using targeted-gene panel sequencing (TPS) and whole-exome sequencing (WES). Plasma adrenal steroids were quantified by liquid chromatography–mass spectrometry and compared to that of controls. This study comprised 18 pediatric endocrinology clinics with 41 patients (17 girls, median age: 3 mo, range: 0-8 y) with non-CAH PAI of unknown etiology. Results A genetic diagnosis was obtained in 29 (70.7%) patients by TPS. Further molecular diagnosis could not be achieved by WES. Compared to a healthy control group, patients showed lower steroid concentrations, most statistically significantly in cortisone, cortisol, and corticosterone (P < .0001, area under the receiver operating characteristic curve: .96, .88, and .87, respectively). Plasma cortisol of less than 4 ng/mL, cortisone of less than 11 ng/mL, and corticosterone of less than 0.11 ng/mL had a greater than 95% specificity to ensure the diagnosis of non-CAH PAI of unknown etiology. Conclusion Steroid hormone profiles are highly sensitive for the diagnosis of non-CAH PAI of unknown etiology, but they are unlikely to point to a specific molecular diagnosis. TPS is an optimal approach in the molecular diagnosis of these patients with high efficacy, whereas little additional benefit is expected from WES.
- Open Access
- 22 December 2021
- Published by Galenos Yayinevi in Medeniyet Medical Journal
- Vol. 36 (4) , 325-332
Assessment of the Nutritional Status, Bone Mineralization, and Anthropometrics of Children with Thalassemia Major
Children with thalassemia major (TM) are prone to growth failure and micronutrient deficiency. Thus, this study aimed to evaluate nutritional status, anthropometrics, and bone mineralization defects in patients with regular blood transfusion. Data obtained were analyzed by evaluating laboratory tests, anthropometric measures, and bone mineral density. This study included 29 patients (62% male and 38% female) with a mean age of 12.26±4.74 years, mean pre-transfusion hemoglobin of 8.64±1.01 g/dL, and mean serum ferritin of 1158.6±556.8 ng/mL. Vitamin D (72.4%), selenium (72.4%), and folate (37.9%) deficiencies were most frequent. Hypocalcemia was observed in 17.2%, hypomagnesemia in 3.5%, and decreased ceruloplasmin in 10.3% of patients. Folate was higher between 2 and 6 years old (p=0.028). Ceruloplasmin was higher between 6 and 10 years old (p=0.018). Selenium was significantly higher in patients with a ferritin of ≥1,500 (p=0.008). No significant ferritin-related differences were found in other micronutrients (p>0.05). Body mass index (BMI) were 95 p. Height in 24.5% and weight in 20.7% of patients were 97 p. BMI of patients aged 10-18 years was significantly higher (p=0.001). Anthropometric percentiles did not significantly differ in the mean serum ferritin and micronutrient levels. Hypoparathyroidism was observed in 13.8% and hypothyroidism in 3.5% of patients. Low bone density was detected in 14.8% (2 osteopenic and 2 osteoporotic) of patients. Bone mineral density did not significantly differ in the ferritin and micronutrient levels. Nutritional support and deficiency prevention are important to minimize the burden of complications and increase the life expectancy and quality in patients with TM.
- 22 December 2021
- Published by Galenos Yayinevi in Medeniyet Medical Journal
- Vol. 36 (4) , 325-332
Open AccessAssessment of the Nutritional Status, Bone Mineralization, and Anthropometrics of Children with Thalassemia Major
Children with thalassemia major (TM) are prone to growth failure and micronutrient deficiency. Thus, this study aimed to evaluate nutritional status, anthropometrics, and bone mineralization defects in patients with regular blood transfusion. Data obtained were analyzed by evaluating laboratory tests, anthropometric measures, and bone mineral density. This study included 29 patients (62% male and 38% female) with a mean age of 12.26±4.74 years, mean pre-transfusion hemoglobin of 8.64±1.01 g/dL, and mean serum ferritin of 1158.6±556.8 ng/mL. Vitamin D (72.4%), selenium (72.4%), and folate (37.9%) deficiencies were most frequent. Hypocalcemia was observed in 17.2%, hypomagnesemia in 3.5%, and decreased ceruloplasmin in 10.3% of patients. Folate was higher between 2 and 6 years old (p=0.028). Ceruloplasmin was higher between 6 and 10 years old (p=0.018). Selenium was significantly higher in patients with a ferritin of ≥1,500 (p=0.008). No significant ferritin-related differences were found in other micronutrients (p>0.05). Body mass index (BMI) were 95 p. Height in 24.5% and weight in 20.7% of patients were 97 p. BMI of patients aged 10-18 years was significantly higher (p=0.001). Anthropometric percentiles did not significantly differ in the mean serum ferritin and micronutrient levels. Hypoparathyroidism was observed in 13.8% and hypothyroidism in 3.5% of patients. Low bone density was detected in 14.8% (2 osteopenic and 2 osteoporotic) of patients. Bone mineral density did not significantly differ in the ferritin and micronutrient levels. Nutritional support and deficiency prevention are important to minimize the burden of complications and increase the life expectancy and quality in patients with TM.
- Open Access
- 1 May 2019
- Published by Elsevier in Jornal de Pediatria (Versão em Português)
- Vol. 95 (3) , 350-357
IL‐17A, MCP‐1, CCR‐2, and ABCA1 polymorphisms in children with non‐alcoholic fatty liver disease
- 1 May 2019
- Published by Elsevier in Jornal de Pediatria (Versão em Português)
- Vol. 95 (3) , 350-357
Open AccessIL‐17A, MCP‐1, CCR‐2, and ABCA1 polymorphisms in children with non‐alcoholic fatty liver disease
- Open Access
- 1 May 2019
- Published by Elsevier in Jornal de Pediatria
- Vol. 95 (3) , 350-357
IL-17A, MCP-1, CCR-2, and ABCA1 polymorphisms in children with non-alcoholic fatty liver disease
- 1 May 2019
- Published by Elsevier in Jornal de Pediatria
- Vol. 95 (3) , 350-357
Open AccessIL-17A, MCP-1, CCR-2, and ABCA1 polymorphisms in children with non-alcoholic fatty liver disease